Trial NCT00900146

View at ClinicalTrials.gov 
Org. Study IDs: CACZ885I2202

Last trial update was posted on 2012-02-20

MeSH Interventions

Metformin

MeSH Conditions

Diabetes Mellitus, Type 2

Other Conditions


Stopping Reasons

Numerically modest lowering of HbA1c with canakinumab in combination with metformin was inadequate to continue patients with T2DM into Period IV of this study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID